Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Purpose. It has been reported that Th2 cytokines downregulate antitumor immunity, while activation of type T cells promotes antitumor immunity. The aim of this paper was to evaluate host immunity in liver cirrhosis (LC) patients with advanced hepatocellular carcinoma (aHCC) receiving sorafenib thera...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nagai, Hidenari, Mukozu, Takanori, Matsui, Daigo, Kanekawa, Takenori, Kanayama, Masahiro, Wakui, Noritaka, Momiyama, Kouichi, Shinohara, Mie, Iida, Kazunari, Ishii, Koji, Igarashi, Yoshinori, Sumino, Yasukiyo
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2012
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359796/
https://ncbi.nlm.nih.gov/pubmed/22666283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/607851
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky